Bilateral rTMS Shows No Advantage in Depression nor in Comorbid Depression and Anxiety: A Naturalistic Study

Psychiatr Q. 2024 Mar;95(1):107-120. doi: 10.1007/s11126-023-10062-7. Epub 2023 Dec 21.

Abstract

The objective was to determine if adding low-frequency right-sided rTMS treatment to the standard high-frequency left-sided treatment (LUL), referred to as sequential bilateral treatment (SBT), confers additional benefit for depression or anxiety outcomes. A retrospective chart review from January 2015 through December 2018 yielded 275 patients, all of whom were treated with a figure-8 coil for a major depressive episode. Their protocol was either LUL or SBL. Outcome measures were the Generalized Anxiety Disorder 7-item scale (GAD-7) and the Patient Health Questionnaire (PHQ-9). There was no significant difference in GAD-7 change scores between patients who had LUL or SBL (4.2 vs 4.8). This was also true when the sample was restricted to only patients who started with high GAD-7 scores. There was likewise no significant difference in PHQ-9 change scores between patients who had LUL or SBL (6.8 vs 5.1). Patients switching from LUL to SBL mid-course had poorer overall outcomes as compared to patients who stayed with the same protocol throughout treatment. This large naturalistic study shows no advantage for SBL treatment any group or condition examined. The results of this study have clinical applicability and sound a cautionary note regarding the use of combination rTMS protocols.

Keywords: Bilateral; Major depressive disorder (MDD); Protocol; Transcranial magnetic stimulation (TMS); Treatment-resistant depression (TRD); Unilateral.

MeSH terms

  • Anxiety / epidemiology
  • Anxiety / therapy
  • Anxiety Disorders / epidemiology
  • Anxiety Disorders / therapy
  • Depression
  • Depressive Disorder, Major* / therapy
  • Depressive Disorder, Treatment-Resistant* / therapy
  • Humans
  • Retrospective Studies
  • Treatment Outcome